TRIM63 and type 2 diabetes mellitus: The essential role of Atrogin-1 and MuRF-1 in maintaining skeletal muscle mass [11], [12], [13] makes these two muscle-specific ubiquitin ligases attractive targets for pharmacological intervention in insulin resistance and type 2 diabetes.